Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 09:40 am Purchase |
2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
AVORO CAPITAL ADVISORS LLC | 4,325,000 8.900% |
1,013,566![]() (+30.61%) |
Filing History |
2023-02-14 09:38 am Purchase |
2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
AVORO CAPITAL ADVISORS LLC | 7,550,000 7.600% |
750,000![]() (+11.03%) |
Filing History |
2023-02-14 09:37 am Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
AVORO CAPITAL ADVISORS LLC | 6,750,000 4.960% |
-500,000![]() (-6.90%) |
Filing History |
2023-02-14 09:37 am Purchase |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 1,660,000 9.700% |
235,000![]() (+16.49%) |
Filing History |
2023-02-14 09:37 am Purchase |
2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
AVORO CAPITAL ADVISORS LLC | 3,850,000 7.000% |
3,850,000![]() (New Position) |
Filing History |
2023-02-14 09:36 am Purchase |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 10,625,000 9.600% |
2,069,445![]() (+24.19%) |
Filing History |
2023-02-14 09:36 am Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,150,000 6.300% |
-85,000![]() (-2.63%) |
Filing History |
2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
AVORO CAPITAL ADVISORS LLC | 26,800,000 9.500% |
8,300,000![]() (+44.86%) |
Filing History |
2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 3,060,000 6.700% |
1,595,000![]() (+108.87%) |
Filing History |
2023-02-14 09:34 am Sale |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 2,865,000 6.300% |
-170,000![]() (-5.60%) |
Filing History |
2023-02-14 09:34 am Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
AVORO CAPITAL ADVISORS LLC | 5,555,555 9.600% |
480,555![]() (+9.47%) |
Filing History |
2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
AVORO CAPITAL ADVISORS LLC | 1,410,000 5.500% |
1,410,000![]() (New Position) |
Filing History |
2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
AVORO CAPITAL ADVISORS LLC | 3,100,000 5.400% |
3,100,000![]() (New Position) |
Filing History |
2023-02-14 09:32 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
AVORO CAPITAL ADVISORS LLC | 3,105,000 4.500% |
-895,000![]() (-22.38%) |
Filing History |
2023-02-14 09:32 am Purchase |
2022-12-31 | 13G | DICE Therapeutics, Inc. DICE |
AVORO CAPITAL ADVISORS LLC | 2,525,555 5.300% |
2,525,555![]() (New Position) |
Filing History |
2023-02-14 09:31 am Sale |
2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
AVORO CAPITAL ADVISORS LLC | 7,020,000 4.400% |
-1,655,000![]() (-19.08%) |
Filing History |
2023-02-14 09:30 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-695,000![]() (Position Closed) |
Filing History |
2022-09-26 5:27 pm Purchase |
2022-09-22 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 3,471,752 14.400% |
1,260,000![]() (+56.97%) |
Filing History |
2022-02-11 10:09 am Unchanged |
2021-12-31 | 13G | POINT Biopharma Global Inc. PNT |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
2022-02-11 10:08 am Sale |
2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-1,525,000![]() (Position Closed) |
Filing History |